ProfileGDS4177 / 201633_s_at
TitleImatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1
OrganismHomo sapiens


KU-812 KCL-22 JURL-MK1 Imatinib untreated Imatinib untreated Imatinib untreated GSM603100 GSM603099 GSM603098 GSM603097 GSM603102 GSM603101 84% 87% 91% 94% 90% 93% sort by cell line sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM603100KU-812 Imatinib-treated292.984
GSM603099KU-812 non-treated387.0487
GSM603098KCL-22 Imatinib-treated610.8791
GSM603097KCL-22 non-treated878.2794
GSM603102JURL-MK1 Imatinib-treated530.2690
GSM603101JURL-MK1 non-treated710.1693